Skip to main content

At Home Care

Home Nursing, Elderly Care & Patient Care Services in Gurgaon | AtHomeCare
AtHomeCare Logo
ATHOMECARE™ KEEPING YOU WELL AT HOME
24×7 Medical Support
+91 99108 23218
Book Consultation

Why is AtHomeCare the Best Home Care in Gurgaon?

AtHomeCare India is the only truly integrated home healthcare provider in Gurgaon, offering all critical services under one roof—without outsourcing.

Essential Thrombocythemia Home Care in Gurgaon | Home Nursing Case Study

Essential Thrombocythemia Home Care in Gurgaon | Home Nursing Case Study
Educational Case Study

Essential Thrombocythemia Home Care in Gurgaon: Managing Thrombosis Risk with Professional Home Nursing

A documented account of how supervised home nursing helped a 59-year-old patient in DLF Phase IV, Gurgaon manage essential thrombocythemia through medication adherence, clotting risk surveillance, and structured caregiver training over eight weeks.

Patient Age
59 Years
Gender
Male
Location
DLF Phase IV, Gurgaon
Primary Condition
Essential Thrombocythemia
Duration of Care
8 Weeks
Clinical Outcome
Stable, No Complications

Patient Background

Mr. Rajeev Malhotra, a 59-year-old business consultant, lived with his wife in DLF Phase IV, Gurgaon. His son, who worked near DLF Cyber City, visited regularly and provided additional support during the care period. Mr. Malhotra led a moderately active professional life before his diagnosis, frequently commuting to client meetings across Gurgaon and Delhi.

His symptoms began gradually. Persistent headaches became a daily occurrence. He noticed occasional dizziness, particularly when standing quickly. Fatigue set in during the afternoons, which he initially attributed to work stress. It was only when routine blood work showed a significantly elevated platelet count that the evaluation leading to his diagnosis was initiated.

Risk Factors Relevant to This Case

  • Age above 60 is an established risk factor for thrombosis in ET, and Mr. Malhotra was approaching this threshold
  • Sedentary work patterns involving long hours at a desk, which independently increase clotting risk
  • Stress associated with a consulting career, potentially contributing to elevated blood pressure
  • No prior history of thrombosis or major bleeding events was documented
  • No known family history of myeloproliferative neoplasms
Daily Life Before Home Care

Mr. Malhotra’s wife managed the household but had no healthcare background. She was aware of his diagnosis and the need for medication but was uncertain about what complications to watch for and how seriously to take symptoms like headaches, which he had been experiencing for months. The family understood that the condition was long-term but did not fully grasp the acute risks, particularly the possibility of a sudden thrombotic event.

Clinical Diagnosis

Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm. In this condition, the bone marrow produces too many platelets without an identifiable secondary cause. Platelets are cells that help blood clot. When present in excessive numbers, they can form clots within blood vessels, blocking blood flow to organs. Paradoxically, very high platelet counts can also be associated with bleeding tendencies because the excess platelets may not function normally.

Understanding the Condition

The central challenge in ET is not the platelet count itself but what that count represents in terms of risk. A patient with ET may feel relatively well for years. The danger is silent. A blood clot can form in a leg vein (deep vein thrombosis), travel to the lungs (pulmonary embolism), or block a cerebral artery causing a stroke. These events can happen without significant warning. This is why monitoring and medication are not optional in ET. They are the primary defense against potentially life-threatening complications.

Presenting Clinical Findings

  • Persistent headaches, likely related to microvascular circulation changes from elevated platelet counts
  • Occasional dizziness on postural change
  • Fatigue affecting afternoon work productivity
  • Elevated platelet count documented on laboratory evaluation
  • No documented history of thrombotic events (deep vein thrombosis, pulmonary embolism, stroke, or transient ischemic attack)
  • No documented abnormal bleeding episodes
Specific platelet count values, hemoglobin levels, white blood cell counts, bone marrow biopsy findings, and JAK2 mutation status were not documented in this case record. The diagnosis and clinical findings described here are based on the documented presentation and the home care assessment summary.
High Risk: Thrombosis. The combination of elevated platelet count, age, and cardiovascular risk factors placed Mr. Malhotra at significant risk for a clotting event, which could manifest as deep vein thrombosis, pulmonary embolism, or stroke.
Moderate Risk: Bleeding. Despite the high platelet count, ET patients can experience abnormal bleeding due to qualitative platelet dysfunction, particularly if antiplatelet or anticoagulant medications are part of the treatment plan.

Hospital Treatment

Mr. Malhotra underwent a comprehensive hospital evaluation after the abnormal blood work was identified. This included specialist hematology consultation, further laboratory investigations, and the initiation of a treatment plan designed to reduce his thrombotic risk while managing symptoms.

Documented Hospital Course

  • Complete hematological workup and specialist consultation confirming the ET diagnosis
  • Initiation of treatment aimed at reducing platelet production and lowering thrombosis risk
  • Assessment of cardiovascular risk factors contributing to overall clotting risk
  • Discharge planning with instructions for continued medication and the need for regular follow-up blood tests
  • No thrombotic or bleeding complications were documented during the hospital stay
Why Hospitalization Was Brief

Unlike acute conditions that require extended hospital stays, ET is a chronic disorder. The hospital’s role was diagnostic confirmation, treatment initiation, and stabilization. Once Mr. Malhotra was placed on an appropriate medication regimen and no acute complications were present, continuing care at home under supervision was a medically sound approach. The real work of managing ET happens over months and years, not days.

Specific medications prescribed, dosage details, transfusion history if any, and the exact discharge criteria were not documented in this case record. The treatment plan was directed by the treating hematologist.

Why Home Healthcare Was Needed

The treating hematologist recommended home nursing services in Gurgaon for Mr. Malhotra after discharge. This recommendation was driven by specific clinical needs that could not be adequately addressed by outpatient visits alone.

Clinical Rationale for Home Nursing

  • Medication adherence verification: ET treatment typically involves daily medication that must be taken consistently. Missing doses directly affects platelet control. A home nurse provides direct observation during the critical early weeks when the medication regimen is new to the patient.
  • Thrombosis symptom surveillance: The most dangerous complication of ET is a blood clot, and it can develop between doctor visits. A trained nurse assesses for leg swelling, pain, redness, sudden shortness of breath, chest pain, neurological changes, and other warning signs during each visit.
  • Bleeding risk monitoring: The treatment itself, which may include antiplatelet agents, can increase bleeding risk. Monitoring for bruising, gum bleeding, blood in urine or stool, and prolonged bleeding from minor cuts is part of safe ET management.
  • Headache and dizziness tracking: These were Mr. Malhotra’s presenting symptoms. Tracking their frequency and severity over time provides useful clinical information for the treating hematologist when adjusting treatment.
  • Hydration management: Adequate hydration reduces blood viscosity, which is particularly important in ET. Ensuring consistent fluid intake is a simple but meaningful intervention.
  • Family caregiver preparation: Mr. Malhotra’s wife needed to understand the difference between normal aches and potential clot symptoms. This distinction is not intuitive and requires structured teaching.
The Critical Difference From Other Blood Disorders

Unlike conditions where the primary risk is infection (such as aplastic anemia), the central risk in ET is a vascular event. This means the home nursing focus shifts from hygiene and isolation to vascular monitoring, hydration, mobility encouragement, and symptom pattern recognition. The sense of urgency is different. A patient with ET may feel entirely well while a clot is silently forming.

Home Care Plan by AtHomeCare

The care plan was developed based on the home care assessment, hospital discharge instructions, and the treating hematologist’s recommendations. It addressed the specific risk profile of a patient with ET living in Gurgaon.

Home Nursing Interventions

A trained nurse provided patient care at home in Gurgaon with the following focus areas:

  • Daily health assessment including vital signs: blood pressure in both arms, heart rate, respiratory rate, temperature, and oxygen saturation
  • Direct observation of medication intake to ensure correct dosage and timing
  • Structured assessment for deep vein thrombosis: inspection and palpation of both lower limbs for swelling, warmth, tenderness, or color change
  • Neurological screening: checking for new or worsening headaches, visual disturbances, speech difficulty, facial asymmetry, or limb weakness
  • Skin examination for unexplained bruising, petechiae, or other bleeding signs
  • Documentation of headache frequency, duration, and character for each visit
  • Coordination with the treating hematologist including relaying clinical observations and facilitating scheduled blood tests

Thrombosis Prevention Strategy

Thrombosis prevention in ET is not limited to medication. It involves modifying factors that contribute to clot formation.

  • Hydration guidance: ensuring a minimum daily fluid intake to reduce blood viscosity, with specific targets discussed and tracked
  • Mobility encouragement: avoiding prolonged sitting, which is particularly relevant for a consultant who works at a desk. Guidance included standing and walking every one to two hours during the day
  • Leg elevation during rest periods to promote venous return
  • Avoidance of tight clothing around the waist and legs that could impair circulation
  • Guidance on travel considerations, particularly for Mr. Malhotra’s professional commute within Delhi NCR
Why Prolonged Sitting Was Specifically Addressed

Mr. Malhotra’s occupation required long periods of seated work. Prolonged sitting is an independent risk factor for deep vein thrombosis, and when combined with a platelet disorder, the risk compounds. The nursing team did not simply tell him to “stay active.” They helped him build a practical schedule that interrupted sitting with short walking breaks without disrupting his work commitments.

Nutrition and Hydration

  • Structured hydration plan with measurable daily intake targets
  • Balanced diet guidance emphasizing whole foods, lean proteins, and adequate fiber
  • No specific dietary restrictions were documented beyond general cardiovascular health principles
  • Guidance on limiting alcohol intake, which can affect platelet function and interact with medications

Family Caregiver Education

Mrs. Malhotra, the primary caregiver, received structured education across multiple nursing visits. Her son participated in two key sessions. The education focused on practical, actionable knowledge rather than theoretical understanding of the disease.

  • How to recognize deep vein thrombosis: unilateral leg swelling, pain or tenderness in the calf, warmth or redness in one leg
  • How to recognize a possible stroke or transient ischemic attack: sudden facial drooping, arm weakness, speech difficulty, sudden severe headache, vision changes
  • How to recognize pulmonary embolism: sudden shortness of breath, chest pain that worsens with deep breathing, coughing up blood
  • How to recognize abnormal bleeding: unexplained bruising, nosebleeds that do not stop within ten minutes, blood in urine or stool, bleeding gums
  • Clear instructions on when to call the home nursing team versus when to go directly to the hospital emergency department
  • Importance of never missing a medication dose and what to do if a dose is accidentally missed
A Practical Education Moment

During the second week, Mrs. Malhotra mentioned that her husband had complained of mild calf discomfort after a long meeting. The nurse used this as a teaching opportunity, performing a bilateral leg comparison and showing Mrs. Malhotra what to look and feel for. The discomfort resolved with movement and hydration, but the experience gave the family a concrete understanding of the surveillance process rather than an abstract list of symptoms.

Recovery Timeline

Day 1
Initial Home Care Assessment in DLF Phase IV

The nursing team conducted the first home visit. The assessment covered current vital signs, medication understanding, home environment suitability, and the family’s knowledge of warning signs. The nurse noted that Mr. Malhotra was compliant but not fully aware of the thrombosis risks. His wife expressed anxiety about “missing something serious.” The home environment was assessed for safety and suitability for recovery.

Day 3
Building the Care Framework
  • Medication supervision began with direct observation of each scheduled dose
  • Baseline headache and dizziness patterns were documented for future comparison
  • Hydration plan was introduced with a daily target discussed and agreed upon
  • Mrs. Malhotra received her first structured education session on thrombosis warning signs
  • Both lower limbs were examined and documented as normal with no signs of thrombosis
Week 1
Establishing Routines
  • Medication adherence was consistent under direct observation
  • Hydration intake improved from baseline but had not yet reached the recommended target
  • Headaches persisted but the nursing team began tracking frequency and severity patterns
  • Mr. Malhotra was encouraged to take short walking breaks during work hours
  • No thrombotic or bleeding symptoms were observed
Week 2
Early Adaptation
  • Hydration targets were being met consistently
  • Mr. Malhotra reported that the walking break routine was becoming habitual
  • The calf discomfort episode occurred and was assessed, providing a practical education opportunity
  • Mrs. Malhotra demonstrated improved ability to describe thrombosis warning signs without referring to written materials
  • Follow-up blood tests were coordinated with the treating hematologist’s clinic
Week 4
Midpoint Review
  • The treating hematologist reviewed follow-up blood results and continued the current treatment plan
  • Headache frequency showed a gradual decrease compared to the first week
  • Mr. Malhotra was managing his daily routine with less nursing direction
  • The son attended an education session and was briefed on emergency response
  • No complications of any kind had occurred
Week 6
Transitioning Toward Independence
  • Medication adherence was reliable without the need for constant supervision
  • Vital signs remained stable across all monitored parameters
  • Mr. Malhotra had resumed light professional activities including some client meetings in Gurgaon
  • Hydration and mobility habits were maintained without daily reminders
  • The nursing team began reducing visit frequency as agreed with the treating doctor
Week 8
Completion of Structured Home Care
  • Platelet levels remained under medical control based on the most recent hematologist review
  • No thrombotic events, bleeding episodes, or other complications occurred during the entire eight-week period
  • Headache frequency had decreased from daily to occasional
  • Mr. Malhotra was managing his medication, hydration, and activity routine independently
  • Mrs. Malhotra expressed confidence in her ability to monitor for warning signs
  • A detailed handover was provided with clear guidelines for ongoing self-management and when to seek medical attention
  • Regular outpatient follow-up with the hematologist was confirmed as the ongoing care pathway

Clinical Monitoring Summary

The following table summarizes the parameters tracked by the home nursing team. No quantitative laboratory values are included, as these were managed directly by the treating hematologist and were not part of the home care documentation.

ParameterWeek 1Week 4Week 8
Blood PressureWithin acceptable rangeWithin acceptable rangeWithin acceptable range
Heart RateNormal, regular rhythmNormal, regular rhythmNormal, regular rhythm
TemperatureNormal, no feverNormal, no feverNormal, no fever
Oxygen SaturationAdequate on room airAdequate on room airAdequate on room air
Lower Limb ExaminationNo swelling, warmth, or tendernessNo swelling, warmth, or tendernessNo swelling, warmth, or tenderness
Neurological ScreeningNo deficits, headaches presentNo deficits, headaches reducedNo deficits, occasional headache
Skin / Bleeding CheckNo abnormal bruising or bleedingNo abnormal bruising or bleedingNo abnormal bruising or bleeding
Headache PatternDaily, moderate intensityReduced to intermittentOccasional, mild
Medication AdherenceConsistent (supervised)ConsistentConsistent (independent)
Hydration StatusBelow targetMeeting targetMeeting target
Functional StatusLimited activity, fatigue presentIncreasing activity toleranceResumed light professional work
Thrombotic EventsNoneNoneNone
All observations in this table are qualitative nursing assessments. Quantitative blood investigations including platelet counts, complete blood counts, and any molecular testing were performed at the treating hematologist’s laboratory and are not reproduced here.

Medical Author and Review

Dr. Ekta Fageriya
Dr. Ekta Fageriya, MBBS
RMC Registration No. 44780
Specialization: Geriatric Medicine
Specialization
Geriatric Medicine
Clinical Experience
7 Years
Registration
RMC 44780
Qualification
MBBS
Treating Physician Details
Treating Doctor
Qualification
Hospital
Medical Registration
Clinical Comments
Future Recommendations

Supporting Clinical Documents

This case study was developed from the home care team’s records and assessment documentation. The following categories of clinical information informed the care plan:

Referenced Documentation

  • Hospital discharge summary: Provided the confirmed diagnosis, treatment initiated, and discharge instructions that formed the foundation of the home care plan
  • Prescription records: Guided medication supervision, dosage verification, and timing schedules
  • Home nursing assessment and progress notes: Daily and weekly documentation of vital signs, symptom tracking, limb examinations, and patient responses
  • Family education records: Documented the topics covered during caregiver training sessions and the family’s demonstrated understanding
Specific laboratory investigation reports, radiology studies, bone marrow biopsy results, and detailed hospital treatment records were not included in the documentation available for this educational case study. All clinical references are derived from the home care team’s records and the treating hematologist’s documented recommendations.

Recovery Outcome

Outcome AreaStatus at Week 8
Thrombotic ComplicationsNone occurred during the eight-week care period
Bleeding ComplicationsNone occurred during the eight-week care period
Platelet ControlRemained under medical control per the treating hematologist’s most recent review
Medication AdherenceProgressed from supervised to independent with consistent compliance
Headache and DizzinessHeadache frequency decreased from daily to occasional; dizziness episodes reduced
Functional StatusResumed light professional activities; increased daily activity tolerance
Hydration and LifestyleMaintained hydration targets and regular mobility breaks independently
Family PreparednessPrimary and secondary caregivers demonstrated confidence in warning sign recognition and emergency response
Outcome: The primary objective of complication-free home management was achieved. No thrombotic or bleeding events occurred. The patient transitioned from supervised care to self-managed care with family support and continued hematologist follow-up.

Remaining Challenges and Long-Term Considerations

  • Essential thrombocythemia is a lifelong condition. The eight-week home care period addressed initial stabilization, not definitive treatment
  • Regular blood tests and hematologist follow-up will be required indefinitely to monitor platelet counts and adjust treatment
  • Thrombosis risk persists long-term and cannot be eliminated, only managed through medication and lifestyle
  • Medication adherence must be maintained for life, which requires ongoing family vigilance
  • Future treatment adjustments may be needed based on blood count trends, age-related risk changes, or new symptoms
  • The patient and family were counselled that this is a marathon, not a sprint, and that consistency matters more than dramatic short-term changes

Key Clinical Learnings

Clinical Insight

Managing ET at home is fundamentally different from managing acute illnesses. There are no dramatic daily changes to monitor. The success of home care in ET is measured by what does not happen: no clots, no bleeds, no missed doses. This requires a different kind of clinical discipline. The nursing team must maintain vigilance even when the patient appears stable, because stability in ET can change without obvious warning.

Observations from This Case

  • The danger in ET is silent. Unlike many conditions where worsening symptoms signal deterioration, a thrombotic event in ET can be the first and only warning. Home nursing provides a layer of surveillance that cannot be replicated by even the most attentive family member without clinical training.
  • Headache tracking has clinical value. In ET, headaches may reflect microvascular circulation changes. Documenting their pattern over weeks gives the hematologist useful information about disease behavior and treatment response, beyond what a single office visit can capture.
  • Lifestyle modification must be practical. Telling a business consultant to “avoid sitting for long periods” is ineffective without helping him integrate walking breaks into his actual work schedule. The nursing team’s role included making the advice actionable within the patient’s real daily routine.
  • Hydration is a low-tech, high-impact intervention. Ensuring adequate fluid intake reduces blood viscosity, which directly addresses one of the mechanisms of thrombosis in ET. It requires no equipment, no prescription, and no expertise to execute, but it does require consistent follow-through that a home nurse can reinforce.
  • Caregiver education must focus on recognition, not theory. Mrs. Malhotra did not need to understand the pathophysiology of myeloproliferative neoplasms. She needed to know what a swollen calf looks like, what a stroke looks like in its earliest stages, and when to call for help. The education was designed around these practical skills.
  • Transition to independence must be deliberate. Moving from supervised medication to self-administration was not an abrupt switch. It was a gradual process where the nursing team reduced direct observation only after observing consistent independent adherence. This graduated approach reduces the risk of adherence dropping when professional oversight is removed.

Frequently Asked Questions

Yes. Patients who have been evaluated by a hematologist, started on appropriate treatment, and cleared for home recovery can safely receive home care in Gurgaon. Professional home nursing services provide the medication supervision and thrombosis surveillance needed to manage ET safely outside the hospital. The key requirement is that the patient must be under active hematologist follow-up.
Home care for ET includes medication adherence monitoring, vital sign assessment, lower limb examination for deep vein thrombosis signs, neurological screening for stroke warning signs, bleeding surveillance, headache and symptom tracking, hydration management, lifestyle counselling, and structured family caregiver education on emergency recognition.
No. Essential thrombocythemia is a chronic condition that currently has no cure. Home care does not treat the disease itself. It supports safe management by ensuring medication compliance, monitoring for complications, and preparing the family to recognize warning signs. The actual treatment is directed by the treating hematologist and continues for the patient’s lifetime.
Blood tests, particularly complete blood counts, are the primary tool for monitoring how well the treatment is controlling platelet production. They also track hemoglobin and white blood cell levels, which can be affected by ET treatment. The results guide the hematologist in adjusting medication doses. Without regular testing, there is no objective way to know whether the treatment is working or whether the dose needs to change.
Warning signs of deep vein thrombosis include swelling, pain, warmth, or redness in one leg (usually the calf). Warning signs of pulmonary embolism include sudden shortness of breath, sharp chest pain that worsens with deep breathing, and coughing up blood. Warning signs of stroke include sudden facial drooping, arm or leg weakness on one side, speech difficulty, confusion, and sudden severe headache. Any of these symptoms require immediate emergency hospital care.
Adequate hydration reduces blood viscosity, meaning it makes the blood slightly thinner and less likely to clot. In a condition where platelet counts are already elevated, keeping the blood at normal viscosity is a practical and meaningful way to reduce thrombosis risk. It is not a replacement for medication, but it is a supportive measure that the patient controls directly.
Most people with ET can continue working, especially once their condition is stabilized on treatment. The important consideration is avoiding prolonged sitting, managing stress, and maintaining hydration during work hours. In this case study, Mr. Malhotra gradually resumed light professional activities. The treating hematologist should guide return-to-work decisions based on the individual’s clinical status and job demands.
This is one of the paradoxical aspects of ET. While the high number of platelets increases the risk of clots forming, the excess platelets may not function normally. They can be less effective at forming proper clots at sites of injury, leading to bleeding tendencies. Additionally, medications used to treat ET, such as antiplatelet agents, further increase bleeding risk. This is why home monitoring must watch for both clotting and bleeding signs.
The duration depends on the patient’s individual situation. In this case, structured patient care at home lasted eight weeks, covering the critical period when the medication regimen was new and the family was building their knowledge base. Some patients may need a shorter or longer supervised period. The treating hematologist and the home care team together determine when the patient is ready to transition to self-management with outpatient follow-up.
Yes. AtHomeCare provides home nursing services across Gurgaon, including areas like DLF Phase IV, DLF Cyber City, Golf Course Road, Sohna Road, Sector 29, MG Road, New Gurgaon, Dwarka Expressway Area, and Old Gurgaon, as well as across Delhi and the broader Delhi NCR. Services are assigned based on the patient’s location, clinical requirements, and the treating doctor’s recommendations.

Contact AtHomeCare

Corporate Office: Unit No. 703, 7th Floor, ILD Trade Centre, D1 Block, Malibu Town, Sector 47, Gurgaon, Haryana 122018
Medical Disclaimer: This is a fictional educational case study created for informational and educational purposes only. It does not represent a real patient, and all names, details, and clinical scenarios are entirely fictional. This content does not constitute medical advice, diagnosis, or treatment recommendation. Every patient is unique, and treatment decisions must always be made by qualified healthcare professionals based on individual clinical evaluation. Emergency symptoms, including sudden chest pain, severe headache, limb swelling, difficulty breathing, uncontrolled bleeding, or stroke-like symptoms, require immediate hospital care. Home healthcare complements but does not replace emergency medical services or specialist treatment.

AtHomeCare. All rights reserved. This content is for educational purposes only.

Leave A Comment

All fields marked with an asterisk (*) are required